1. Morag Martin (Glasgow) - benzodiazepine withdrawal regimens
2. Paul Foster ? Antipsychotic equivalent doses?

1. ?
2. Stephen Bazire (Norwich) - Psychotropic Aide Memoire, a fore-runner of the Psychotropic Drug Directory

1. Alison Adams and Stephen Bazire (Norwich) - Bespoke patient information leaflets
2. Carol Paton and Brian Tissington (Bexley) - training and education book

1. Helen Baxter (Leeds) - lithium and ACE inhibitors interaction
2. Graham Parton (Leicester) - lithium side effects

1. Lynn Haygarth (Leeds) - use of clonidine and naltrexone
2. Dominique-Jeanne Lepaux (France) and Jacqueline Surugue (Allones) - Nosocomial infections in French Psychiatric Hospitals

1. Carol Paton (Bexley) - carbamazepine use
2. Dora Greenway - clozapine in chronic schizophrenia
3. Linda Fellows (Graylands) and Diedre Alderton (Western Australia) - pharmacist input on prescribing

1. David Branford (Leicester) - prevalence of TD in LD
2. Marjorie Stoddart (Wirral) - prescribing evaluation
3. Linda Rossiter and Christopher Mitchell (Sunderland) - lithium monitoring chart

1. Brett Hill (Cardiff) - depot antipsychotics review
2. John Donoghue (Liverpool) - problems with drugs on discharge

1. Nader Siabi (Herts and Essex)
2. Moinuddin Kolia (Blackburn) - a drug investigation

1. Jennie Day (Liverpool) - LUNSERS
2. Julie Wilson (Sheffield) - Pharmacists, community care and LD

1. Dr. Jennie Day (Liverpool)
2. Rob Holmes and colleagues (London)

1. Helen Shaw (Glasgow)
2. Kathryn Carter (Leicester)

1. Helen Shaw (Woodilee Hospital)
2. Stephen Bazire (Norwich) - web site for patients www.nmhc.co.uk, later becoming www.nwmhp.nhs.uk/pharmacy

1. Jean Stubbs (Northampton) - olanzapine study
2. Christine Hastie (Caterham)

1. Carol Paton (Bexley)
2. Lynn Haygarth (Leeds)

1. Nurjehan Moledina (London)
2. Shimeem Mir (London)

1. Diane Harris (Derby) - investigating community pharmacists roles

1. Denise Duncan-McConnell (London) - patient education
   Stuart Banham (Oxleas, Bexley) - clinical governance publications
   Betsy Wilkie - patient information leaflets for people with learning disabilities

1. Joy Nicholson, Edinburgh (QA system to manage patients on high-dose antipsychotics)
   
2. Petra Brown, Manchester (Effectiveness of clozapine in a population-based mirror-image study)
   
3. Diane Harris, Derby (Compliance and care for elderly people with mental health problems)

1. Pat Morgan, Abergavenney (near-patient lithoum clinic)
   
2. Lee Knowles, Oldham (non-clinical factors affecting prescribing of antipsychotics in secure units)

1. Fiona Couper and Orla Daly, Catterbridge (An investigation of in-patient lithium therapy management)
   
2. Bren Holmes and Stephen Bazire, Norwich (The trials and tribulations of setting up a county-wide lithium database)
   
3. Claire Norton, John Marriott and Sima Iftikhar, (A review of the use of antipsychotics in child and adolescent psychiatric patients)

1. Jayne Kinder and Emma Cutler, Derby (A mental health Pharmacy admission support service)
   
2. Graham Newton and Janet Ward, Liverpool (Serum clozapine concentration assays - re-engineering a local service)

1. Kiran Parmar, (Clozapine Assay)
   
2. Pat Morgan, Powis (Lithium "on the spot" testing)
   
3. Gail Healey, Basildon and Thurrock, An audit of co-prescribing of atypical and conventional antipsychotics

1. Shubra Mace, Maudsley (An audit of Risperdal Consta)
   
2. Joan Miller and Janette McEwan, Bolton, Salford and Trafford (Clozapine home delivery service)

1. Carol Paton, Radia Esop and Chike Okocha, Bexley
   
2. Ian Maidment, Kent, use of Anticholinesterases in Parkinson's Disease Dementia: a critical analysis of benefits

1. Joan Miller, Salford, clozapine red alert
   
   Editor's note: have I missed anything here? Please let me know.

1. Producing drug information videos for deaf service users; Ciara Sarah Hallows and Caroline Falconbridge (Birmingham)
2. Dr Dave Branford (Derby), e-learning in mental health education
   
   Highly commended:
   
   Corina Young and Dr. David Taylor (Maudsley), a mirror image study of Risperdal Consta
   
   Deborah Reeves (Plymouth), development of pharmacy services to a Community Mental health team
   
   Paul Deslandes, L Raitt, Arwel Thomas and RDF Sewell (Cardiff); the effectiveness of antimuscarinic agents in the treatment of clozapine-induced hypersalivation
   
   Carol Paton (Bexley) Outcomes after switching to generic clozapine

1. Ray Lyons (Sussex), Utilising PANSS-EC scoring to minimise the risks of parenteral rapid tranquillisation Highly commended:
   
   Walter Broekema, Will the pharmacist become a film producer? Videoclips as a Quality Improvement Tool
   
   Paul Deslandes, Cardiff, Is reducing dopaminergic function a forgotten factor in suicidality associated with SSRIs?

1. Stephen Bleakley (London) - What antipsychotic would you take yourself?
2. Lynn Haygarth and Dr K Zehry - clinican views of Risperdal Consta (Leeds)
3. Maria McIntyre (Essex) - The prescribing of drugs for the side effects of antipsychotics
4. Salwa Morcos (Kent) - What does CAT teach us?

1. Ciara Hallows (Birmingham) - Using BSL for patient information

1. Erica Young
2. Joan Miller

1. John Donoghue (Liverpool) - hypnotic prescribing in depression
2. Pat Morgan (Abergavenney) - olanzapine audit
3. Justine Raynsford (Leeds) - carers group medication education

Presentations
1. Caroline Parker, Central and North West London NHS Foundation Trust, Medication Management clinic

2. Amanda Wheeler, University of Otago, Christchurch, New Zealand, Clinical Review and Audit of Antipsychotic Prescribing in Schizophrenia